Suppr超能文献

葡萄牙中部地区甲硝唑耐药和敏感的幽门螺杆菌临床分离株中 rdxA 和 frxA 基因突变的研究。

Study of rdxA and frxA genes mutations in metronidazole-resistant and -susceptible Helicobacter pylori clinical isolates from the central region of Portugal.

机构信息

Centro do Sangue e da Transplantação de Coimbra, Instituto Português do Sangue e da Transplantação, IP, Coimbra, Portugal.

CIMAGO, Faculty of Medicine, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.

出版信息

J Glob Antimicrob Resist. 2019 Jun;17:300-304. doi: 10.1016/j.jgar.2019.01.008. Epub 2019 Jan 15.

Abstract

OBJECTIVES

Helicobacter pylori is one of the most prevalent global pathogens colonising an estimated 50% of the world's population. Although metronidazole (MTZ) is an important antibiotic playing a relevant role in various H. pylori eradication therapies, its frequent consumption results in an increased frequency of resistance with a consequent negative impact on treatment efficacy. Mutations on genes encoding NADPH nitroreductases, commonly known as rdxA gene (oxygen-insensitive) and frxA gene (flavinreductase) have been associated to H. pylori resistance to metrodinazole. The aim of this study was to evaluate the mutation profile of rdxA and frxA genes in a population of 38 H. pylori isolates with phenotypic patterns of susceptibility and resistance to this antibiotic.

METHODS

Touchdown PCR with the purpose of amplifying rdxA and frxA genes in one PCR was used. Sequence data were made by pair-wise sequence alignment and were examined in terms of codons, and comparison was achieved regarding amino acids.

RESULTS

Although repeated mutations occurred in positions 118, 131, 172 and 183 of rdxA and in positions 72, 73, 110, 126 and 193 of frxA, it must be highlighted that the mutations are widespread along these two genes in this population. Furthermore, six MTZ-resistant isolates did not present any mutation in the frxA gene.

CONCLUSIONS

This work appears to confirm that mutations in rdxA and frxA alone are unable to explain MTZ resistance in H. pylori isolates and therefore additional mechanisms may exist and should be investigated.

摘要

目的

幽门螺杆菌是全球最普遍的病原体之一,估计有 50%的世界人口受到其感染。甲硝唑(MTZ)虽然是一种重要的抗生素,在各种幽门螺杆菌根除治疗中发挥着重要作用,但由于其频繁使用,导致耐药性增加,从而对治疗效果产生负面影响。编码 NADPH 硝基还原酶的基因(通常称为 rdxA 基因[耐氧]和 frxA 基因[黄素还原酶])的突变与幽门螺杆菌对甲硝唑的耐药性有关。本研究旨在评估 38 株幽门螺杆菌分离株的 rdxA 和 frxA 基因突变谱,这些分离株对该抗生素的表型表现为敏感性和耐药性。

方法

采用降落式 PCR 技术,在一个 PCR 中扩增 rdxA 和 frxA 基因。通过序列两两比对进行序列数据分析,并对密码子和氨基酸进行比较。

结果

虽然 rdxA 基因的 118、131、172 和 183 位以及 frxA 基因的 72、73、110、126 和 193 位重复发生突变,但必须强调的是,这些突变在该人群中广泛存在于这两个基因中。此外,6 株 MTZ 耐药分离株的 frxA 基因未发生任何突变。

结论

本研究似乎证实,rdxA 和 frxA 基因中的突变单独不能解释幽门螺杆菌分离株对 MTZ 的耐药性,因此可能存在其他机制,需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验